表紙:世界の鎌状赤血球治療市場:治療モダリティ別(骨髄移植、輸血、薬物療法)、エンドユーザー別(病院、専門クリニック、その他)、地域別予測(2021~2027年)
市場調査レポート
商品コード
1027551

世界の鎌状赤血球治療市場:治療モダリティ別(骨髄移植、輸血、薬物療法)、エンドユーザー別(病院、専門クリニック、その他)、地域別予測(2021~2027年)

Global Sickle Cell Treatment market is segmented by Treatment Modality (Bone Marrow Transplant, Blood Transfusion, and Pharmacotherapy), End User (Hospitals, Specialty Clinics, and Others),Regional Forecasts 2021-2027

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.75円
世界の鎌状赤血球治療市場:治療モダリティ別(骨髄移植、輸血、薬物療法)、エンドユーザー別(病院、専門クリニック、その他)、地域別予測(2021~2027年)
出版日: 2021年09月07日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の鎌状赤血球治療の市場規模は、2021年から2027年の予測期間に13%以上の健全な成長率で拡大すると予測されています。

鎌状赤血球症は、酸素を含んだ血液を運搬する分子であるヘモグロビンに障害が生じる疾患カテゴリーです。鎌状または三日月状の変形した赤血球がこの疾患を患う患者に見られます。鎌状赤血球症の症状は、一般的に幼児期に始まり、思春期まで続きます。赤血球の形が変化していく過程で、赤血球が早期に破壊され、貧血を引き起こすことがあります。鎌状赤血球貧血の治療の目的は、不快感の軽減、痛みの緩和、合併症の予防です。思春期や10代の若者の中には、投薬や輸血による治療を受ける人もいます。

同市場を牽引しているのは、研究開発活動の活発化と鎌状赤血球症の有病率の増加です。例えば、National Health Instituteによると、世界の鎌状赤血球症患者の90%以上が3つの国に居住しています。ナイジェリア、インド、コンゴ民主共和国の3カ国では、鎌状赤血球症の患者数が人口の2%に達しており、保因者率(鎌状赤血球形質)は10%から30%と高い数値を示しています。しかし、治療費の高さが、2021~2027年年の予測期間における市場の成長を妨げる可能性があります。

当レポートでは、世界の鎌状赤血球治療市場について調査し、市場の概要とともに、治療モダリティ別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の鎌状赤血球治療市場の定義と範囲

第3章 世界の鎌状赤血球治療市場力学

  • 鎌状赤血球治療市場の影響分析(2019~2027年)

第4章 世界の鎌状赤血球治療市場業界分析

  • ポーターの5フォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論

第5章 世界の鎌状赤血球治療市場、治療モダリティ別

  • 市場スナップショット
  • 世界の鎌状赤血球治療市場、治療モダリティ別:パフォーマンス-潜在的な分析
  • 世界の鎌状赤血球治療市場の見積と予測、治療モダリティ別:2018~2027年(10億米ドル)
  • 鎌状赤血球治療市場、サブセグメント分析
    • 輸血
    • 骨髄移植
    • 薬物療法

第6章 世界の鎌状赤血球治療市場、エンドユーザー別

  • 市場スナップショット
  • 世界の鎌状赤血球治療市場、エンドユーザー別:パフォーマンス-潜在的な分析
  • 世界の鎌状赤血球治療市場の見積と予測、エンドユーザー別:2018~2027年(10億米ドル)
  • 鎌状赤血球治療市場、サブセグメント分析
    • 病院
    • 専門クリニック
    • その他

第7章 世界の鎌状赤血球治療市場、地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他
  • アジア太平洋のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第8章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Bristol Myers Squibb Co.
    • Global Blood Therapeutics Inc.
    • Bluebird Biotechnology
    • F.Hoffmann-La Roche
    • Emmaus Medical Inc.
    • Eli-Lilly and Co.
    • Baxter Inc.
    • Medunik USA.Inc.
    • Addmedica Inc.
    • Glycomimetics Inc

第9章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Sickle Cell treatment Market, report scope
  • TABLE 2. Global Sickle Cell treatment Market estimates & forecasts by region 2018-2027 (USD Billion)
  • TABLE 3. Global Sickle Cell treatment Market estimates & forecasts by Treatment Modality 2018-2027 (USD Billion)
  • TABLE 4. Global Sickle Cell treatment Market estimates & forecasts by End User 2018-2027 (USD Billion)
  • TABLE 5. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 6. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 7. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 19. Global Sickle Cell treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 20. Global Sickle Cell treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. U.S. Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 22. U.S. Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 23. U.S. Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 24. Canada Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 25. Canada Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. Canada Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 27. UK Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 28. UK Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. UK Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 30. Germany Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 31. Germany Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. Germany Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 33. France Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 34. France Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. France Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 36. Spain Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 37. Spain Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. Spain Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 39. Italy Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 40. Italy Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. Italy Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 42. ROE Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 43. ROE Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. ROE Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 45. China Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 46. China Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. China Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 48. India Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 49. India Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. India Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 51. Japan Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 52. Japan Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. Japan Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 54. Australia Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 55. Australia Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. Australia Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 57. South Korea Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 58. South Korea Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 59. South KoreaSickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 60. ROPAC Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 61. ROPAC Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 62. ROPAC Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 63. Brazil Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 64. Brazil Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 65. Brazil Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 66. Mexico Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 67. Mexico Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 68. Mexico Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 69. ROLA Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 70. ROLA Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 71. ROLA Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 72. ROW Sickle Cell treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 73. ROW Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 74. ROW Sickle Cell treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 75. List of secondary sources used in the study of Global Sickle Cell treatment Market.
  • TABLE 76. List of primary sources used in the study of Global Sickle Cell treatment Market.
  • TABLE 77. Years considered for the study.
  • TABLE 78. Exchange rates considered.

LIST OF FIGURES

List of figures

  • FIG 1. Global Sickle Cell treatment Market, research methodology
  • FIG 2. Global Sickle Cell treatment Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Sickle Cell treatment Market, key trends 2020
  • FIG 5. Global Sickle Cell treatment Market, growth prospects 2021-2027
  • FIG 6. Global Sickle Cell treatment Market, porters 5 force model
  • FIG 7. Global Sickle Cell treatment Market, pest analysis
  • FIG 8. Global Sickle Cell treatment Market, value chain analysis
  • FIG 9. Global Sickle Cell treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Sickle Cell treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Sickle Cell treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Sickle Cell treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Sickle Cell treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Sickle Cell treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 15. Global Sickle Cell treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 16. Global Sickle Cell treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 17. Global Sickle Cell treatment Market, regional snapshot 2018 & 2027
  • FIG 18. North America Sickle Cell treatment Market 2018 & 2027 (USD Billion)
  • FIG 19. Europe Sickle Cell treatment Market 2018 & 2027 (USD Billion)
  • FIG 20. Asia-Pacific Sickle Cell treatment Market 2018 & 2027 (USD Billion)
  • FIG 21. Latin America Sickle Cell treatment Market 2018 & 2027 (USD Billion)
  • FIG 22. Global Sickle Cell treatment Market, company market share analysis (2020)
目次

Global Sickle Cell treatment Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 13% over the forecast period 2021-2027. Sickle cell disease is a category of diseases that impair hemoglobin, the molecule that transports oxygenated blood. A deformed red blood cell with the shape of a sickle or crescent is found in people with this disease. Symptoms of sickle cell disease generally begin in early childhood and continue throughout adolescence. Red blood cells break down prematurely as they alter form, which can cause anaemia. The aim of sickle cell anaemia treatment is to reduce discomfort, relieve pain, and prevent complications. Some adolescents and teens are treated with medications and blood transfusions. The market is driven by the increasing research and development activity and increasing prevalence of sickle cell disease. For instance, as per the National Health Institute, over 90% of the world's SCD population resides in three countries: Nigeria, India, and the Democratic Republic of Congo, where the disease affects up to 2% of the population and the carrier prevalence rate (sickle cell trait) is as high as 10% to 30%. However, high cost of treatments may impede market growth over the forecast period of 2021-2027.

Geographically, the sickle cell treatment market in North America is dominated by the United States, which is the market's biggest contributor. Improved access to SCD treatment and potential pipeline medicines are attributed with the region's growth. The substantial government support in the United States will help promote the market's healthy growth.

Major market player included in this report are:

Bristol Myers Squibb Co.

Global Blood Therapeutics Inc.

Bluebird Biotechnology

F.Hoffmann-La Roche

Emmaus Medical Inc.

Eli-Lilly and Co.

Baxter Inc.

Medunik USA.Inc.

Addmedica Inc.

Glycomimetics Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Modality:

Blood Transfusion

Bone Marrow Transplant

Pharmacotherapy

By End user:

Hospitals

Specialty Clinics

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027.

Target Audience of the Global Sickle Cell treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Sickle Cell treatment Market, by Region, 2019-2027 (USD Billion)
    • 1.2.2. Sickle Cell treatment Market, by Treatment Modality, 2019-2027 (USD Billion)
    • 1.2.3. Sickle Cell treatment Market, by End user, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Sickle Cell treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Sickle Cell treatment Market Dynamics

  • 3.1. Sickle Cell treatment Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing research and development activity
      • 3.1.1.2. Increasing prevalence of sickle cell disease
    • 3.1.2. Market Restraint
      • 3.1.2.1. High cost of treatments
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Widespread population of African descent

Chapter 4. Global Sickle Cell treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Sickle Cell treatment Market, by Treatment Modality

  • 5.1. Market Snapshot
  • 5.2. Global Sickle Cell treatment Market by Treatment Modality, Performance - Potential Analysis
  • 5.3. Global Sickle Cell treatment Market Estimates & Forecasts by Treatment modality 2018-2027 (USD Billion)
  • 5.4. Sickle Cell treatment Market , Sub Segment Analysis
    • 5.4.1. Blood Transfusion
    • 5.4.2. Bone Marrow Transplant
    • 5.4.3. Pharmacotherapy

Chapter 6. Global Sickle Cell treatment Market, by End user

  • 6.1. Market Snapshot
  • 6.2. Global Sickle Cell treatment Market by End User, Performance - Potential Analysis
  • 6.3. Global Sickle Cell treatment Market Estimates & Forecasts by End User 2018-2027 (USD Billion)
  • 6.4. Sickle Cell treatment Market , Sub Segment Analysis
    • 6.4.1. Hospitals
    • 6.4.2. Specialty Clinics
    • 6.4.3. Others

Chapter 7. Global Sickle Cell treatment Market, Regional Analysis

  • 7.1. Sickle Cell treatment Market , Regional Market Snapshot
  • 7.2. North America Sickle Cell treatment Market
    • 7.2.1. U.S. Sickle Cell treatment Market
      • 7.2.1.1. Treatment modality breakdown estimates & forecasts, 2018-2027
      • 7.2.1.2. End user breakdown estimates & forecasts, 2018-2027
    • 7.2.2. Canada Sickle Cell treatment Market
  • 7.3. Europe Sickle Cell treatment Market Snapshot
    • 7.3.1. U.K. Sickle Cell treatment Market
    • 7.3.2. Germany Sickle Cell treatment Market
    • 7.3.3. France Sickle Cell treatment Market
    • 7.3.4. Spain Sickle Cell treatment Market
    • 7.3.5. Italy Sickle Cell treatment Market
    • 7.3.6. Rest of Europe Sickle Cell treatment Market
  • 7.4. Asia-Pacific Sickle Cell treatment Market Snapshot
    • 7.4.1. China Sickle Cell treatment Market
    • 7.4.2. India Sickle Cell treatment Market
    • 7.4.3. Japan Sickle Cell treatment Market
    • 7.4.4. Australia Sickle Cell treatment Market
    • 7.4.5. South Korea Sickle Cell treatment Market
    • 7.4.6. Rest of Asia Pacific Sickle Cell treatment Market
  • 7.5. Latin America Sickle Cell treatment Market Snapshot
    • 7.5.1. Brazil Sickle Cell treatment Market
    • 7.5.2. Mexico Sickle Cell treatment Market
  • 7.6. Rest of The World Sickle Cell treatment Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Bristol Myers Squibb Co.
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Global Blood Therapeutics Inc.
    • 8.2.3. Bluebird Biotechnology
    • 8.2.4. F.Hoffmann-La Roche
    • 8.2.5. Emmaus Medical Inc.
    • 8.2.6. Eli-Lilly and Co.
    • 8.2.7. Baxter Inc.
    • 8.2.8. Medunik USA.Inc.
    • 8.2.9. Addmedica Inc.
    • 8.2.10. Glycomimetics Inc

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption